India's Pharmaceutical Exports

Country Profile

Kyrgyzstan

Kyrgyzstan is an emerging destination for Indian pharmaceutical exports — $23.2M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 60% of shipments, with vaccines contributing $3.57M. The compound annual growth rate since FY2016 stands at 13.8%.

🇰🇬 $23.2M · 3.6× growth since FY2016 · 13.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$23.2M
Exports FY2025–26 DGCIS
3.6×
Growth FY2016→2026
13.8%
CAGR FY2016→2026
60%
Medicines Share
5
Product Categories Supplied
Kyrgyzstan is an emerging destination for Indian pharmaceutical exports — $23.2M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 60% of shipments, with vaccines contributing $3.57M. The compound annual growth rate since FY2016 stands at 13.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $14.0M (60.4%) Medicine Ingredients $5.33M (23.0%) Vaccines $3.57M (15.4%) Surgical & Hospital Supplies $170K (0.7%) Traditional & Herbal $109K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Kyrgyzstan in the RBI overseas direct investment dataset (2011–2026).